Serotonin Synthesis Amplification is distinct from existing serotonergic pharmacologies, e.g., selective serotonin reuptake inhibitors (SSRIs), which remove a brake on serotonin neurotransmission, and psychedelics, which activate select serotonin receptors
DiMarchis quote as follows: Many diseases share the same root causes, which is inhibition of AMPK activity leading to disruption of many metabolic pathways. GLP-1 drugs activate AMPK primarily through reducing calorie intake
Lilly is studying it in obesity, type 2 diabetes, knee osteoarthritis pain, obstructive sleep apnea, chronic kidney disease, cardiovascular outcomes and liver disease
What is BPC-157 used for in laboratory studies
Nutrition for the mother
The authors found that patients with peripheral arterial disease were able to walk comfortably for longer times and distances after using PLC